Sylvain Broussy

953 total citations · 1 hit paper
37 papers, 724 citations indexed

About

Sylvain Broussy is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Sylvain Broussy has authored 37 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Organic Chemistry and 8 papers in Epidemiology. Recurrent topics in Sylvain Broussy's work include Angiogenesis and VEGF in Cancer (12 papers), Click Chemistry and Applications (6 papers) and Tuberculosis Research and Epidemiology (5 papers). Sylvain Broussy is often cited by papers focused on Angiogenesis and VEGF in Cancer (12 papers), Click Chemistry and Applications (6 papers) and Tuberculosis Research and Epidemiology (5 papers). Sylvain Broussy collaborates with scholars based in France, United States and China. Sylvain Broussy's co-authors include David B. Berkowitz, Michel Vidal, Bernard Meunier, Jean Bernadou, Lei Wang, Wang‐Qing Liu, Annaı̈k Quémard, Ross W. Cheloha, Michel Nguyen and Yukari Maezato and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Sylvain Broussy

37 papers receiving 713 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis

2024 61 citations Lei Wang, Wang‐Qing Liu et al. Frontiers in Pharmacology profile →

Peers

Countries citing papers authored by Sylvain Broussy

Since Specialization

Citations

This map shows the geographic impact of Sylvain Broussy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Broussy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Broussy more than expected).

Fields of papers citing papers by Sylvain Broussy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Broussy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Broussy. The network helps show where Sylvain Broussy may publish in the future.

Co-authorship network of co-authors of Sylvain Broussy

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Broussy. A scholar is included among the top collaborators of Sylvain Broussy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Broussy. Sylvain Broussy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis breakdown → 2024 ·Frontiers in Pharmacology ·Lei Wang, Wang‐Qing Liu, Sylvain Broussy, Bingnan Han, (unknown)	61
2	A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities 2023 ·Pharmaceuticals ·(unknown), Hossein Ghafouri, (unknown), Amir Reza Aref, Ebrahim Mostafavi, (unknown), Saeed Balalaie, Sylvain Broussy, S. Mohsen Asghari	18
3	A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics 2021 ·Molecules ·Xiaoqing Ye, Jean‐François Gaucher, Michel Vidal, Sylvain Broussy	21
4	A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor Activities 2021 ·Frontiers in Pharmacology ·Lei Wang, Meng Xu, (unknown), Lun Zhang, Fei Ye, Jia Jin, (unknown), Jian Chen, Guiqian Chen, Sylvain Broussy, Michel Vidal, Zhengbing Lv, Wang‐Qing Liu	3
5	Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application 2020 ·Signal Transduction and Targeted Therapy ·Afsaneh Sadremomtaz, (unknown), (unknown), Saeed Balalaie, (unknown), Sylvain Broussy, Kamran Mansouri, Matthew R. Groves, S. Mohsen Asghari	21
6	Synthesis of indole inhibitors of silent information regulator 1 (SIRT1), and their evaluation as cytotoxic agents 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Yuou Teng, Patrick Deschamps, Michel Vidal, Peng Yu, Sylvain Broussy	12
7	Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat) 2020 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Sylvain Broussy, (unknown), Michel Vidal	55
8	Post-stroke pathway analysis and link with one year sequelae in a French cohort of stroke patients: the PAPASePA protocol study 2019 ·BMC Health Services Research ·Sylvain Broussy, François Rouanet, (unknown), (unknown), (unknown), (unknown), (unknown), Patrick Dehail, Antoine Bénard, Jérôme Wittwer, Roger Salamon, Igor Sibon, F. Saillour-Glénisson	7
9	Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2 2019 ·European Journal of Medicinal Chemistry ·Lei Wang, Pascale Coric, Sylvain Broussy, Rossella Di Stasi, (unknown), Luca Domenico D’Andrea, Lili Ji, Michel Vidal, Serge Bouaziz, Wang‐Qing Liu	8
10	VEGFR1 domain 2 covalent labeling with horseradish peroxidase: Development of a displacement assay on VEGF 2017 ·Analytical Biochemistry ·Marie Reille‐Seroussi, Jean‐François Gaucher, (unknown), Isabelle Broutin, Michel Vidal, Sylvain Broussy	3
11	Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A 2016 ·PLoS ONE ·Jonathan Gaucher, Marie Reille‐Seroussi, Nathalie Gagey‐Eilstein, Sylvain Broussy, Pascale Coric, Bili Seijo, Marie‐Bernard Lascombe, Benoît Gautier, (unknown), Florent Huguenot, Nicolas Inguimbert, Serge Bouaziz, Michel Vidal, Isabelle Broutin	13
12	Mini-ISES identifies promising carbafructopyranose-based salens for asymmetric catalysis: Tuning ligand shape via the anomeric effect 2015 ·Science Advances ·Kannan R. Karukurichi, Xiang Fei, (unknown), Sylvain Broussy, Weijun Shen, Sangeeta Dey, Sandip Kumar Roy, David B. Berkowitz	11
13	Couverture par le vaccin de la grippe saisonnière des médecins généralistes et de leurs patients. Enquête de pratique auprès de médecins généralistes français après la campagne de vaccination 2011–2012 2014 ·Revue d Épidémiologie et de Santé Publique ·(unknown), (unknown), Shérazade Kinouani, Sylvain Broussy, Marie-Quitterie Picat, (unknown), (unknown)	5
14	Combinatorial Catalysis Employing a Visible Enzymatic Beacon in Real Time: Synthetically Versatile (Pseudo)Halometalation/Carbocyclizations 2011 ·Angewandte Chemie International Edition ·(unknown), Sylvain Broussy, Woo Jin Chung, David B. Berkowitz	24
15	Combinatorial Catalysis Employing a Visible Enzymatic Beacon in Real Time: Synthetically Versatile (Pseudo)Halometalation/Carbocyclizations 2011 ·Angewandte Chemie ·(unknown), Sylvain Broussy, Woo Jin Chung, David B. Berkowitz	4
16	Solid Phase Synthesis of Highly Substituted Tetrahydropyrans by Tandem ene-Reaction/Intramolecular Sakurai Cyclization 2007 ·Journal of Combinatorial Chemistry ·Sylvain Broussy, Herbert Waldmann	8
17	Guanine Oxidation by Electron Transfer: One‐ versus Two‐Electron Oxidation Mechanism 2005 ·ChemBioChem ·(unknown), Aude Saulière, Sylvain Broussy, (unknown), Geneviève Pratviel, Bernard Meunier	30
18	¹H and¹³C NMR characterization of pyridinium-type isoniazid–NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis 2005 ·Organic & Biomolecular Chemistry ·Sylvain Broussy, (unknown), Yannick Coppel, Annaı̈k Quémard, Jean Bernadou, Bernard Meunier	8
19	Studies on the 4-benzoylpyridine-3-carboxamide entity as a fragment model of the Isoniazid–NAD adduct 2005 ·Organic & Biomolecular Chemistry ·Sylvain Broussy, (unknown), Heinz Gornitzka, Jean Bernadou, Bernard Meunier	12
20	¹H and ¹³C NMR Characterization of Hemiamidal Isoniazid‐NAD(H) Adducts as Possible Inhibitors Of InhA Reductase of Mycobacterium tuberculosis 2003 ·Chemistry - A European Journal ·Sylvain Broussy, Yannick Coppel, Michel Nguyen, Jean Bernadou, Bernard Meunier	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact